Infectious Complications of Bio-Alcamid Filler Used for HIV-Related Facial Lipoatrophy | Zendy

Jeya Nadarajah | Zendy; Micaela L. Collins | Zendy; J. Raboud | Zendy; DeSheng Su | Zendy; K. S. Rao | Zendy; Mona Loutfy | Zendy; Sharon Walmsley | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Infectious Complications of Bio-Alcamid Filler Used for HIV-Related Facial Lipoatrophy

Author(s) -

Jeya Nadarajah,

Micaela L. Collins,

J. Raboud,

DeSheng Su,

K. S. Rao,

Mona Loutfy,

Sharon Walmsley

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis745

Subject(s) - medicine , interquartile range , surgery , incidence (geometry) , lipoatrophy , adverse effect , human immunodeficiency virus (hiv) , retrospective cohort study , antiretroviral therapy , viral load , immunology , physics , optics

Human immunodeficiency virus (HIV)-related facial lipoatrophy is a devastating adverse effect of antiretroviral therapy. At this time, the most viable treatment option is cosmetic surgery with synthetic fillers. Bio-Alcamid has many advantages over other fillers, and has become widely used. The objective of this study was to determine the incidence rate of infectious complications associated with Bio-Alcamid facial filler in patients with HIV-related facial lipoatrophy (FLA).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research